BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38845941)

  • 1. Comprehensive pan-cancer analysis reveals the versatile role of GALNT7 in epigenetic alterations and immune modulation in cancer.
    Liu Y; Sun Y; Xiao M; Li S; Shi S
    Heliyon; 2024 Jun; 10(11):e31515. PubMed ID: 38845941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis of ART1 and its Potential Value in Gastric Cancer.
    Wu Z; Song S; Zhou J; Zhang Q; Yu J
    J Cancer; 2024; 15(12):3684-3707. PubMed ID: 38911388
    [No Abstract]   [Full Text] [Related]  

  • 3. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
    Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
    Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune modulation and prognostic significance of MCM10 in pan-cancer: a comprehensive analysis.
    Abdel-Maksoud MA; Iqbal K; Gull S; Kumar SK; Mastoor M; Almutairi SM; Almanaa TN; Alfuraydi AA; Mubarak A; Kotob MH; Jamil M; Zaky MY
    Am J Transl Res; 2023; 15(11):6451-6463. PubMed ID: 38074804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways.
    Abdel-Maksoud MA; Ullah S; Nadeem A; Khan QUA; Zia MK; Ali S; Zakri AM; Almanaa TN; Alfuraydi AA; Al-Qahtani WH; Hameed Y
    Am J Transl Res; 2023; 15(11):6464-6475. PubMed ID: 38074816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLIPR2: a potential biomarker and therapeutic target unveiled - Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.
    Lin W; Zhang S; Gu C; Zhu H; Liu Y
    Front Immunol; 2024; 15():1280525. PubMed ID: 38476239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of O-linked glycosyltransferase GALNT7 in breast cancer is dependent on estrogen-, progesterone-, and HER2-receptor status, with prognostic implications.
    Berkel C; Cacan E
    Glycoconj J; 2023 Dec; 40(6):631-644. PubMed ID: 37947928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
    Scott E; Hodgson K; Calle B; Turner H; Cheung K; Bermudez A; Marques FJG; Pye H; Yo EC; Islam K; Oo HZ; McClurg UL; Wilson L; Thomas H; Frame FM; Orozco-Moreno M; Bastian K; Arredondo HM; Roustan C; Gray MA; Kelly L; Tolson A; Mellor E; Hysenaj G; Goode EA; Garnham R; Duxfield A; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Bogdan D; Westaby D; Fowler G; Flohr P; Yuan W; Sharp A; de Bono J; Maitland NJ; Wisnovsky S; Bertozzi CR; Heer R; Guerrero RH; Daugaard M; Leivo J; Whitaker H; Pitteri S; Wang N; Elliott DJ; Schumann B; Munkley J
    Oncogene; 2023 Mar; 42(12):926-937. PubMed ID: 36725887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses.
    Wang J; Gilani SF; Noor N; Ahmed MR; Munazir M; Zubair A; Sultan R; Abdel-Maksoud MA; Saleh IA; Zomot N; Kodous AS; Ibrahim SS; El-Tayeb MA; Aufy M; Zaky MY; Hassan SS; Hameed Y
    Am J Transl Res; 2024; 16(3):738-754. PubMed ID: 38586115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
    Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
    J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment.
    Yadav G; Kulshreshtha R
    Life Sci; 2024 Feb; 339():122438. PubMed ID: 38242493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-30c facilitates natural killer cell cytotoxicity to lung cancer through targeting GALNT7.
    Gao F; Han J; Jia L; He J; Wang Y; Chen M; Liu X; He X
    Genes Genomics; 2023 Feb; 45(2):247-260. PubMed ID: 36040682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.
    Wu H; Chen J; Li D; Liu X; Li L; Wang K
    Transl Oncol; 2017 Dec; 10(6):876-885. PubMed ID: 28926745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
    Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
    Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.
    Peng RQ; Wan HY; Li HF; Liu M; Li X; Tang H
    J Biol Chem; 2012 Apr; 287(17):14301-9. PubMed ID: 22399294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment.
    Wu Z; Pan T; Li W; Zhang YH; Guo SH; Liu Y; Zhang L; Wang ZY
    Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38642258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.
    Khan R; Pari B; Puszynski K
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.